115 related articles for article (PubMed ID: 3457411)
1. [Chronic myeloid leukemia: comparison of monotherapy with busulfan with busulfan and vincristine and 6-mercaptopurine cycles].
Cervantes F; Rozman C; Nomdedeu B; Blade J; Montserrat E
Rev Clin Esp; 1986 Jan; 178(1):4-7. PubMed ID: 3457411
[No Abstract] [Full Text] [Related]
2. [Treatment of acute adult myeloblastic leukemia with intensive chemotherapy].
Sayas MJ; Sanz MA; Martín-Aragonés G; Javier Rafecas F; Martínez JA; Lorenzo IJ; Sanz GF; Gomis F; Marty ML
Sangre (Barc); 1986; 31(6):718-29. PubMed ID: 3470955
[No Abstract] [Full Text] [Related]
3. Vindesine-prednisone in the treatment of blast crisis of chronic myeloid leukemia.
Lemoine F; Najman A; Laporte JP; Gorin NC; Duhamel G
Cancer Treat Rep; 1985 Feb; 69(2):203-4. PubMed ID: 3855698
[TBL] [Abstract][Full Text] [Related]
4. Combination chemotherapy for chronic granulocytic leukaemia.
Resegotti L; Dolci C
Haematologica; 1981 Oct; 66(5):709-10. PubMed ID: 6796479
[No Abstract] [Full Text] [Related]
5. [Evaluation of two methods of maintenance chemotherapy with methotrexate and 6-mercaptopurine for childhood acute lymphoblastic leukemia].
Kawai S; Fujimoto T; Hiyoshi Y; Nibu K; Ito M; Kadoya S; Shingaki Y
Rinsho Ketsueki; 1984 Jun; 25(6):819-26. PubMed ID: 6384569
[No Abstract] [Full Text] [Related]
6. [Cytogenetic and therapeutic results of a protocol including splenectomy and intensive polychemotherapy in Ph'-positive chronic myeloid leukemia].
Cervantes F; Rozman C; Ballesta F; Milá M
Sangre (Barc); 1986; 31(3):297-302. PubMed ID: 3462920
[No Abstract] [Full Text] [Related]
7. Treatment of myeloid blastic crisis of chronic myelogenous leukemia.
Preisler HD; Raza A; Higby D; Kirshner J; Woll J; Bennett J; Winton L; Weiner R; Richman C; Golomb H
Cancer Treat Rep; 1984 Nov; 68(11):1351-5. PubMed ID: 6388833
[TBL] [Abstract][Full Text] [Related]
8. [The therapeutic results in acute myeloid leukemias in elderly patients].
Parovichnikova EN; Savchenko VG; Isaev VG; Tikhonova LIu; Sarycheva TG; Kulikov SM
Ter Arkh; 1992; 64(8):87-9. PubMed ID: 1440406
[No Abstract] [Full Text] [Related]
9. [A case of refractory acute myeloblastic leukemia who achieved partial remission by high dose cytosine arabinoside].
Okamoto S; Ogata H; Yoshida T; Oheda Y; Murase T; Toyama K
Rinsho Ketsueki; 1984 May; 25(5):719-23. PubMed ID: 6590900
[No Abstract] [Full Text] [Related]
10. [24-year survival in chronic myeloid leukemia].
Müller L; Hehlmann R
Klin Wochenschr; 1987 Jul; 65(14):673-6. PubMed ID: 3476806
[TBL] [Abstract][Full Text] [Related]
11. [The results of 2 and 1/2 years of work of the Russian Multicenter Trial on the Treatment of Acute Myeloid Leukemias in Adults].
Savchenko VG; Parovichnikova EN; Gliasova GA; Isaev VG; Kulikov SM; Tikhonova LIu; Cherepanova VV; Rekhtman GB; Medvedeva NV; Kaporskaia TS
Ter Arkh; 1995; 67(7):8-12. PubMed ID: 7482315
[No Abstract] [Full Text] [Related]
12. [A CML case of 3-year survival after a myeloid blastic crisis treated with VP therapy and steroid pulse therapy].
Suemaru S; Hirakawa S; Yamamoto N; Kageyama J; Ota Z; Kitajima K; Sakamoto K; Kamura J
Rinsho Ketsueki; 1986 Apr; 27(4):589-93. PubMed ID: 3461188
[No Abstract] [Full Text] [Related]
13. Randomized study of individualized induction therapy with or without VCR, and of maintenance of 4 or 12 courses in adult AML: JALSG-AML87. Japan Adult Leukemia Study Group (JALSG).
Ohno R; Kobayashi T; Morishima Y; Hiraoka A; Imai K; Asoh N; Tsubaki K; Tomonaga M; Takahashi I; Kodera K
Leukemia; 1992; 6 Suppl 2():92-5. PubMed ID: 1578954
[TBL] [Abstract][Full Text] [Related]
14. [Clinical studies of BH-AC-DMP in adult acute nonlymphocytic leukemia].
Kato Y; Kawashima K; Ohno R; Yamada K
Nihon Ketsueki Gakkai Zasshi; 1983 Sep; 46(5):1077-86. PubMed ID: 6582751
[No Abstract] [Full Text] [Related]
15. Treatment of chronic myeloid leukemia with repeated single doses of busulfan.
Sullivan JR; Hurley TH; Bolton JH
Cancer Treat Rep; 1977; 61(1):43-5. PubMed ID: 266418
[TBL] [Abstract][Full Text] [Related]
16. DNA as a carrier for anthracyclines in the treatment of acute myelocytic leukemia (AML).
Gahrton G; Tidefelt U; Paul C; Björkholm M; Grimfors G; Hast R; Juliusson G; Järnmark M; Killander A; Kimby E
Leukemia; 1992; 6 Suppl 2():89-91. PubMed ID: 1578953
[No Abstract] [Full Text] [Related]
17. [The use of intermediate dose cytosine arabinoside (ID Ara-C) in the treatment of relapsing or refractory cases of acute myelogenous leukemia].
Kawano F; Tejima Y; Tajima H; Lee SY; Shiozaki A; Nakai R; Chyosa M; Sawada T; Maeda Y; Mizokuni T
Rinsho Ketsueki; 1986 Mar; 27(3):315-20. PubMed ID: 3461178
[No Abstract] [Full Text] [Related]
18. Improved outcome in childhood acute myeloid leukemia in Singapore with the MRC AML 10 protocol.
Tan RM; Quah TC; Aung L; Liang S; Kirk RC; Yeoh AE
Pediatr Blood Cancer; 2007 Mar; 48(3):262-7. PubMed ID: 16602120
[TBL] [Abstract][Full Text] [Related]
19. Treatment of chronic myelomonocytic leukemia. Vincristine and prednisone therapy during symptomatic phase or after transformation to acute leukemia.
Taetle R; Haerr R
West J Med; 1985 Oct; 143(4):524-7. PubMed ID: 3867198
[No Abstract] [Full Text] [Related]
20. Busulphan versus combination chemotherapy for initial treatment of chronic granulocytic leukaemia.
Jacobs P
Am J Hematol; 1986 Aug; 22(4):375-80. PubMed ID: 3460327
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
